Fascin is a clinical biomarker for metastatic cancer, and cells overexpressing fascin feature an overabundance of filopodia-like protrusions that mediate enhanced tissue invasion and migration, which are correlated with poor prognosis30–37. Here, FSCN1 is linked to metastatic malignant neoplasm.